informaworld logo
HOME . ABOUT US . CONTACT US 		HELP . PUBLISH WITH US . LIBRARIANS 
ebooks logo journals logo reference works logo abstract databases logo
bullet  SIGN IN Register | Why Register? | Got a Voucher? alerts   marked lists   shopping cart 
Advert: Informa Healthcare - http://www.informahealthcare.com

informaworld

HOME   |   SEARCH   |   BROWSE
    Issues List       Latest Issue       Forthcoming Articles       Volume 49 Issue 11       Aims & Scope       Editorial Board       Instructions for Authors       Subscribe      
<< earliestearliest   < prevprev   Issue listissues   next >next   latest >>latest
Publisher Logo Publication Cover
Search within this journal

Leukemia and Lymphoma, Volume 49 Issue 11 2008

Leukemia and Lymphoma is moving!
2008 Impact Factor: 1.939 (© Thomson Reuters, Journal Citation Reports®, 2009)
ISSN: 1029-2403 (electronic) 1042-8194 (paper)
Publication Frequency: 12 issues per year
Viewing the Journal: Select the initial letter of your research topic from the list below, or enter your search term on the left.
Sort by: Title | Page | Author
< Previous • 1 • 2 • Next >
View new articles ahead of the print edition
select-down Click for help
Commentaries
Prognosis of mantle cell lymphoma: is it all about proliferation?
Oliver Weigert; Martin Dreyling
Pages 2029 – 2030
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Hodgkin lymphoma and interleukin-10: shall we go down from the tip of the iceberg?
Otavio C. G. Baiocchi
Pages 2031 – 2032
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
T-cell lymphoma – one name with a dozen faces
Andrei R. Shustov
Pages 2033 – 2034
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Rituximab – a double-edged sword: can one treatment for thrombocytopenia also induce it?
Ron Ram; Pia Raanani
Pages 2035 – 2036
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
The dilemma of jaw osteonecrosis in patients with multiple myeloma
Morie A. Gertz; Sreenivas Koka
Pages 2037 – 2039
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
In vitro chemosensitivity testing in the genomic era
R. Eric Davis
Pages 2040 – 2041
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Reviews
High-dose chemotherapy supported by autologous stem cell transplantation in patients with primary central nervous system lymphoma: facts and opinions
Andrés J. M. Ferreri;  Roberto Crocchiolo;  Andrea Assanelli;  Silvia Govi; Michele Reni
Pages 2042 – 2047
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-κB pathway as a target for new therapeutic strategies
Alessandro Pavan;  Michele Spina;  Vincenzo Canzonieri;  Silvia Sansonno;  Giuseppe Toffoli; Valli De Re
Pages 2048 – 2058
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Preclinical versus clinical drug combination studies
Ting-Chao Chou
Pages 2059 – 2080
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Original Articles: Clinical
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study
Eric D. Hsi;  Sin-Ho Jung;  Raymond Lai;  Jeffrey L. Johnson;  James R. Cook;  Dan Jones;  Sven Devos;  Bruce D. Cheson;  Lloyd E. Damon; Jonathan Said
Pages 2081 – 2090
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma
Roger Rautert;  Timo Schinköthe;  Jeremy Franklin;  Martin Weihrauch;  Boris Böll;  Elke Pogge;  Henning Bredenfeld;  Andreas Engert;  Volker Diehl; Daniel Re
Pages 2091 – 2098
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States
Abeer N. Abouyabis;  Pareen J. Shenoy;  Mary Jo Lechowicz; Christopher R. Flowers
Pages 2099 – 2107
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL
Alison Morilla;  David Gonzalez de Castro;  Ilaria Del Giudice;  Nnenna Osuji;  Monica Else;  Ricardo Morilla;  Vasantha Brito Babapulle;  Hannah Rudenko;  Estella Matutes;  Claire Dearden;  Daniel Catovsky; Gareth J. Morgan
Pages 2108 – 2115
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Rituximab-associated changes in platelet count in patients with non-Hodgkin lymphoma
Stefan Wilop;  Oliver Galm;  Reyad Dada;  Rainhardt Osieka; Edgar Jost
Pages 2116 – 2124
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Primary lymphoma of bone: an institutional experience
Joseph P. Catlett;  Stephen A. Williams;  Shannon C. O'Connor;  Jayashree Krishnan; Vera Malkovska
Pages 2125 – 2132
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemia
Hideyuki Koharazawa;  Heiwa Kanamori;  Rika Sakai;  Chizuko Hashimoto;  Sachiya Takemura;  Michiko Hattori;  Jun Taguchi;  Katsumichi Fujimaki;  Naoto Tomita;  Hiroyuki Fujita;  Shin Fujisawa;  Hiroshi Harano;  Koji Ogawa;  Shigeki Motomura;  Atsuo Maruta; Yoshiaki Ishigatsubo
Pages 2133 – 2140
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial
Sucha Nand;  John Godwin;  Scott Smith;  Kevin Barton;  Laura Michaelis;  Serhan Alkan;  Ranjitha Veerappan;  Karen Rychlik;  Eliza Germano; Patrick Stiff
Pages 2141 – 2147
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Prospective monocentric study of non-tunnelled central venous catheter-related complications in hematological patients
Anna Maria Nosari;  Guido Nador;  Andrea De Gasperi;  Giuseppe Ortisi;  Alberto Volonterio;  Silvia Cantoni;  Michele Nichelatti;  Laura Marbello;  Ernestina Mazza;  Valentina Mancini;  Erica Ravelli;  Francesca Ricci;  Denis Ciapanna;  Federica Garrone;  Giovanni Gesu; Enrica Morra
Pages 2148 – 2155
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates
Vittorio Montefusco;  Francesca Gay;  Francesco Spina;  Rosalba Miceli;  Massimo Maniezzo;  Maria Teresa Ambrosini;  Lucia Farina;  Sheila Piva;  Antonio Palumbo;  Mario Boccadoro; Paolo Corradini
Pages 2156 – 2162
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		 buy now buy now
select-up

Privacy Policy | Terms & Conditions | Accessibility | RSS
FAQs in: English . Français . Español . 中文（简体和繁體）
© 2009 Informa plc